Efficacy and safety of durable versus biodegradable polymer drug-eluting stents in patients with acute myocardial infarction complicated by cardiogenic shock

Efficacy and safety of durable versus biodegradable polymer drug-eluting stents in patients with acute myocardial infarction complicated by cardiogenic shock

Abstract The clinical impact of different polymer technologies in newer-generation drug-eluting stents (DESs) for patients with acute myocardial infarction (AMI) complicated by cardiogenic shock (CS) remains poorly understood. We investigated the efficacy and safety of durable polymer DESs (DP-DESs)...

Full description

Bibliographic Details
Main Authors:	Woo Jin Jang, Ik Hyun Park, Ju Hyeon Oh, Ki Hong Choi, Young Bin Song, Joo-Yong Hahn, Seung-Hyuk Choi, Hyeon-Cheol Gwon, Chul-Min Ahn, Cheol Woong Yu, Hyun-Joong Kim, Jang-Whan Bae, Sung Uk Kwon, Hyun Jong Lee, Wang Soo Lee, Jin-Ok Jeong, Sang-Don Park, Jeong Hoon Yang
Format:	Article
Language:	English
Published:	Nature Portfolio 2024-03-01
Series:	Scientific Reports
Subjects:	Polymers Drug-eluting stent Cardiogenic shock Myocardial infarction
Online Access:	https://doi.org/10.1038/s41598-024-56925-2

Similar Items

Clinical significance of lactate clearance in patients with cardiogenic shock: results from the RESCUE registry
by: Ik Hyun Park, et al.
Published: (2021-10-01)

Inodilators May Improve the In-Hospital Mortality of Patients with Cardiogenic Shock Undergoing Veno-Arterial Extracorporeal Membrane Oxygenation
by: Mijoo Kim, et al.
Published: (2022-08-01)

Culprit‐Only Versus Immediate Multivessel Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction Complicating Advanced Cardiogenic Shock Requiring Venoarterial‐Extracorporeal Membrane Oxygenation
by: Ki Hong Choi, et al.
Published: (2023-05-01)

Impact of the Obesity Paradox Between Sexes on In‐Hospital Mortality in Cardiogenic Shock: A Retrospective Cohort Study
by: Woochan Kwon, et al.
Published: (2022-06-01)

Differential Prognostic Impact of IABP-SHOCK II Scores According to Treatment Strategy in Cardiogenic Shock Complicating Acute Coronary Syndrome: From the RESCUE Registry
by: Bum Sung Kim, et al.
Published: (2024-01-01)

Prediction of In‐Hospital Mortality for Ischemic Cardiogenic Shock Requiring Venoarterial Extracorporeal Membrane Oxygenation
by: Joo Hee Jeong, et al.
Published: (2024-02-01)

Non-culprit left main coronary artery disease in acute myocardial infarction complicated by cardiogenic shock.
by: Ik Hyun Park, et al.
Published: (2023-01-01)

Non-culprit left main coronary artery disease in acute myocardial infarction complicated by cardiogenic shock
by: Ik Hyun Park, et al.
Published: (2023-01-01)

Comparison of in‐hospital outcomes of patients with vs. without ischaemic cardiomyopathy undergoing veno‐arterial‐extracorporeal membrane oxygenation
by: Seok‐Woo Seong, et al.
Published: (2021-08-01)

Cardiogenic shock teams and centres: a contemporary review of multidisciplinary care for cardiogenic shock
by: Nima Moghaddam, et al.
Published: (2021-04-01)

Comparison of 7-Year, Real-World Clinical Outcomes between Drug-Coated Balloon Angioplasty versus Drug-Eluting Stent Implantation in Patients with Drug-Eluting Stent In-Stent Restenosis
by: Minsu Kim, et al.
Published: (2023-06-01)

Transarterial chemoembolization using drug eluting beads for the treatment of hepatocellular carcinoma: Now and future
by: Hyun Young Woo, et al.
Published: (2015-12-01)

Multidisciplinary team approach in acute myocardial infarction patients undergoing veno-arterial extracorporeal membrane oxygenation
by: David Hong, et al.
Published: (2020-06-01)

Comparison of 3-year clinical outcomes between Endeavor Resolute® and Resolute Integrity® zotarolimus-eluting stents in an Asian population
by: Yong Hoon Kim, et al.
Published: (2020-04-01)

Clinical safety and effectiveness of the Genoss drug-eluting stent in real-world clinical practice
by: Young Jin Youn, et al.
Published: (2023-09-01)

Comparison of Long‐Term Clinical Outcome Between Multivessel Percutaneous Coronary Intervention Versus Infarct‐Related Artery–Only Revascularization for Patients With ST‐Segment–Elevation Myocardial Infarction With Cardiogenic Shock
by: Joo Myung Lee, et al.
Published: (2019-12-01)

A meta-analysis of everolimus-eluting stents versus sirolimus-eluting stents and paclitaxel-eluting stents in diabetic patients
by: Hang Ouyang, et al.
Published: (2021-04-01)

Comparison of the Major Clinical Outcomes for the Use of Endeavor® and Resolute Integrity® Zotarolimus-Eluting Stents During a Three-Year Follow-up
by: Yong Hoon Kim, et al.
Published: (2020-02-01)

Cardiopulmonary resuscitation with assisted extracorporeal life support during cardiac arrest caused by drug-eluting stent thrombosis: a case report
by: Ju-Hyun Lee, et al.
Published: (2014-05-01)

Predictors of in-hospital mortality after successful weaning of venoarterial extracorporeal membrane oxygenation in cardiogenic shock
by: Joo Hee Jeong, et al.
Published: (2023-10-01)

Intravascular imaging analysis of a drug-eluting balloon followed by a bare metal stent compared to a drug-eluting stent for treatment of de novo lesions
by: Wonsuk Choi, et al.
Published: (2019-07-01)

Effectiveness and Safety of Contemporary Drug-Eluting Stents in Patients With Diabetes Mellitus
by: Yujin Yang, MD, et al.
Published: (2021-09-01)

Clinical Outcomes of Biodegradable versus Durable Polymer Drug Eluting Stents in Rotational Atherectomy: Results from ROCK Registry
by: Kyung An Kim, et al.
Published: (2022-10-01)

When measuring leads to better outcome in cardiogenic shock
by: Holger Thiele
Published: (2020-12-01)

Hypoalbuminemia and Albumin Replacement during Extracorporeal Membrane Oxygenation in Patients with Cardiogenic Shock
by: Jae Beom Jeon, et al.
Published: (2023-07-01)

Clinical Significance of Low-Flow Time in Patients Undergoing Extracorporeal Cardiopulmonary Resuscitation: Results from the RESCUE Registry
by: Ik Hyun Park, et al.
Published: (2020-11-01)

Efficacy and Safety of Dual-Drug-Eluting Stents for de Novo Coronary Lesions in South Korea—The Effect Trial
by: Jung-Joon Cha, et al.
Published: (2020-12-01)

Clinical results of everolimus-eluting stents and sirolimus-eluting stents in patients undergoing percutaneous coronary intervention
by: Iraj Jafaripour, et al.
Published: (2023-05-01)

Piperlongumine-Eluting Gastrointestinal Stent Using Reactive Oxygen Species-Sensitive Nanofiber Mats for Inhibition of Cholangiocarcinoma Cells
by: Hyung Ha Jang, et al.
Published: (2019-02-01)

Long-Term Clinical Outcomes Between Biodegradable and Durable Polymer Drug-Eluting Stents: A Nationwide Cohort Study
by: Seung-Jun Lee, et al.
Published: (2022-04-01)

MUMPS MYOCARDITIS AS A CAUSE OF NEONATAL CARDIOGENIC SHOCK
by: M. Kadivar, et al.
Published: (2008-05-01)

Bifurcation strategies using second-generation drug-eluting stents on clinical outcomes in diabetic patients
by: Jung-Joon Cha, et al.
Published: (2022-12-01)

Differential effect of left ventricular unloading according to the aetiology of cardiogenic shock
by: Jeehoon Kang, et al.
Published: (2024-02-01)

Cardiogenic oscillation induced ventilator autotriggering
by: Narender Kaloria, et al.
Published: (2015-08-01)

Long-term Outcomes of Drug-eluting Stents in Symptomatic Intracranial Stenosis
by: Soonchan Park, et al.
Published: (2013-02-01)

Long coverage with drug-eluting stents is superior to spot coverage for long femoropopliteal artery disease: PARADE II study
by: Jong-Il Park, et al.
Published: (2022-10-01)

Clinical outcomes of biodegradable polymer biolimus-eluting BioMatrix stents versus durable polymer everolimus-eluting Xience stents.
by: Da Hyon Lee, et al.
Published: (2017-01-01)

Dopamine versus norepinephrine as the first-line vasopressor in the treatment of cardiogenic shock
by: Soo Jin Na, et al.
Published: (2022-01-01)

Dopamine versus norepinephrine as the first-line vasopressor in the treatment of cardiogenic shock.
by: Soo Jin Na, et al.
Published: (2022-01-01)

The management of patients with cardiogenic shock
by: Marcin Sadowski, et al.
Published: (2017-03-01)